Close Menu
    What's Hot

    Royal Horticultural Society 1974 Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

    August 17, 2026

    Athora To Sell German Business to Frankfurter Leben

    August 17, 2026

    The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

    August 13, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Royal Horticultural Society 1974 Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

      August 17, 2026

      Athora To Sell German Business to Frankfurter Leben

      August 17, 2026

      Talcott Financial Group, Goldman Sachs Launch West Grove Re

      August 5, 2026

      Lincoln Financial Reinsures Universal Life Block With Talcott

      August 3, 2026

      US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

      August 13, 2026

      Shaping the Future of Health Insurance Through Innovation and Analytics

      June 10, 2026

      Q&A: Dr Christoph Schmitt, Director, Insurance, Fitch Ratings

      May 28, 2026

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Life Carriers Eyeing VM-22 for a Pension Risk Transfer Pricing Advantage in 2027

      August 12, 2026

      Elementis Group Pension Scheme Completes Bulk Purchase Annuity Buy-In With Aviva

      August 5, 2026

      Hickson UK Group Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

      August 3, 2026

      UK Insurance Company Pension Scheme Completes Bulk Purchase Annuity Transaction With M&G

      August 3, 2026

      Record Low Mortality Rates So Far in England and Wales in 2026

      July 9, 2026

      Organ Transplant Improvements Test Life Expectancy Assessment Models

      July 8, 2026

      The Pursuit of Everlasting Life Unlikely to Shift Actuarial Models

      June 10, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026

      The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

      August 13, 2026

      New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

      August 12, 2026

      The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

      August 12, 2026

      Corry Capital Advisors Adds John Daniel as Senior Director of Analytics and AI Strategy

      August 6, 2026

      Royal Horticultural Society 1974 Pension Scheme Completes Bulk Purchase Annuity Transaction With Royal London

      August 17, 2026

      Athora To Sell German Business to Frankfurter Leben

      August 17, 2026

      The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

      August 13, 2026

      US Individual Life Insurance Sales Continue Growth Trend in the Second Quarter

      August 13, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 8, August 2026

      August 12, 2026

      Editor’s Letter – Volume 2, Issue 7, July 2026

      July 8, 2026

      Editor’s Letter – Volume 2, Issue 6, June 2026

      June 10, 2026

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    New Drivers of Life Settlement Transactions Emerging to Provide Industry With Added Fuel for Growth

    Secondary Life Markets June 14, 2023By Greg Winterton
    Life Insurance
    Share
    Twitter LinkedIn Email

    Reasons abound why seniors in the United States might seek to sell their whole life insurance policy to a third-party investor. Two of the most frequently cited are that the insured simply can’t afford the premiums anymore – and so selling their policy via a life settlement gets them more cash than the surrender value offered by the insurance company – and the need to be able to fund medical bills or pay off a mortgage.

    Many life settlement sales run into five, six, and even seven figures, depending on the policy value. But the more financially savvy American seniors are increasingly seeing life insurance as part of an overall asset allocation model, which in turn is driving more of them to view life insurance as one part of a broader portfolio, something which can be changed depending on the prevailing market environment and their risk appetite.

    “Seniors are increasingly undertaking an opportunity cost analysis of maintaining their life insurance policy versus re-deploying that capital to other investment opportunities, such as private investments like real estate,” said Aaron Giroux, CEO at Los Angeles, CA-based life settlements provider, LifeRoc Capital. “This is one of the fastest growing reasons that we see people exploring the life settlement option.”

    Activity generally in the secondary market is seen to be on the up. The Life Insurance Settlement Association (LISA), a Washington, DC-based trade association, unveiled its annual transaction data survey results at its investor conference in May; 3,079 deals were completed by 20 providers in 2022, an improvement on the 2,998 in 2021 – when three additional firms participated in the survey.

    Giroux says that he expects that number to push even higher when 2023 is said and done.

    “We anticipate that the secondary market will transact around 3,250 deals this year. The general chatter in the industry is that policy submissions are going up.”

    Not all whole life policies that hit the market get bought, however. Reasons abound for this, including that brokers tend to focus on larger face value policies, restricting supply, and some of the smaller face value policies and younger insureds are perceived as too risky. But this year, those seniors that are managing to realise a sale are considered a safer bet.

    “The capital that is in the market at the moment is looking for paper that is less risky – that is, policies with a low probability of survival to maturity. These policies are not really trading at any discount rate,” said Giroux.

    Whilst brokers remain a significant source of deal flow for life settlement providers, particularly in the medium-higher face value segment of the secondary market, other types of third parties are increasingly getting involved in another boon to those active in the market.

    “The direct-to-consumer channel has driven a lot of awareness, but we’re also seeing a trend of origination coming through the institutional market. Much of the existing US advisor base is ageing out of the industry, and the newer blood is much less independent and more closely aligned banks, broker dealers, and other institutional players,” said Giroux. “Plus, we’re seeing sourcing direct from CPAs and attorneys, which is down to the educational efforts that the industry has been involved in.”

    The industry’s tertiary market is experiencing changes in drivers of supply, both structural and cyclical. Macroeconomic factors are also having an impact on the tertiary market; Giroux says that activity in 2022 was higher than in 2021, with one driver being the impact of higher interest rates on portfolios.

    “There was some forced selling last year. Some of it is redemption management by open-ended funds and some funds that utilise leverage have had to sell to manage debt and lines of credit. Both of these have brought supply onto the tertiary market last year,” he said.

    One permanent source of blocks of policies in the market is that of closed-ended funds which are at their end-of-life, so the manager simply sells the remaining policies in the portfolio to liquidate the fund entirely and returns the remaining capital to investors. But an industry that largely operated on a ‘buy and hold’ strategy is increasingly displaying an interesting change in behaviour.

    “One of the developments that’s most impacting the tertiary market is that more and more asset managers are approaching life settlements as an actively managed asset class, like an equity hedge fund would,” said Giroux. “Previously, this was something of a ‘set it and forget it’ space, but now the core thesis has evolved to the extent that portfolio managers are actively trading in and out of assets during the life of the fund, re-deploying that capital, and not waiting to the end of the fund’s life to execute sell side opportunities.”

    Ultimately, the impact of the macroeconomy on activity in the life settlement market may last a while longer. But for Giroux, what’s most notable is that the changes that are having the biggest impact, both in the secondary and tertiary markets, are those which are of a more fundamental nature.

    “We need a constant supply of new policies in order for our industry to grow,” he said. “I’m mostly encouraged by the developments in the secondary market, like the growth in direct-to-consumer, and the increase in different types of advisors and fiduciaries playing in the space, that should support continued growth in the coming years.”

    2023 - June Life Settlements Volume 2 Issue 6 - June 2023
    Share. Twitter LinkedIn Email

    Related Posts

    The Royal Society of Chemistry Pension Scheme Completes Bulk Purchase Annuity Buy-in With PIC

    August 13, 2026By LMI Newsdesk

    New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

    August 12, 2026By Greg Winterton

    The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

    August 12, 2026By Fergus Bescoby

    Corry Capital Advisors Adds John Daniel as Senior Director of Analytics and AI Strategy

    August 6, 2026By LMI Newsdesk
    Latest Issue

    New Life Settlement Provider Data Illustrates Continued Evolution of Secondary Life Settlement Market

    August 12, 2026

    The Crucial Role of Regular Medical Record Reviews in Life Settlement Investments

    August 12, 2026

    US Life Carriers Eyeing VM-22 for a Pension Risk Transfer Pricing Advantage in 2027

    August 12, 2026

    End-Game Clarity Shaping UK Pension Risk Transfer Market but Large Schemes Still on the Sidelines

    July 22, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.